Search
for
Sort by
Research 721–750 of 1000+
- 519 Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
- Efficacy of finasteride for treating patients with androgenetic alopecia who are pileous in other areas: A pilot study in Japan
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Efficacy of a mixed preparation containing piperine, capsaicin and curcumin in the treatment of alopecia areata
- Hot Stuff: Thermal Imaging Aids in Cellulitis Diagnosis
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- A Novel Treatment of Acne Vulgaris Using a 1927 nm Fractional Thulium Laser: A Case Series
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Application of Platelet-Rich Plasma as a Stem Cell Treatment - anAttempt to Clarify a Common Public Misconception
- Smoker’s Mustache Revisited: Upper Lip Hair Yellow Discoloration Associated With Tobacco
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Efficacy and safety of compound glycyrrhizin combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials
- Patient prioritisation of items to develop the Patient‐Reported Impact of Dermatological Diseases measure: A global Delphi study
- Cardiovascular risk markers in premature canities
- Menopause and Common Dermatoses: A Systematic Review
- Treatment of Lichen Planopilaris With Abrocitinib
- Bicalutamide in Dermatology: A Narrative Review
- LB1056 Phase 1b: Translational evaluation of VYN201, a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo
- A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor
- Capryloyl glycine and soy isoflavonoids in hypertrichosis: An experimental and placebo‐controlled clinical study
- Crescent‐shaped incisional cuts: An unusual complication with Q‐switched Nd:YAG 1064 laser tattoo removal
- British Hair and Nail Society
- 608 A clinical study to test the efficacy of VB1953 in clindamycin non-responder acne patients with antibiotic-resistant P. acnes
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- Ambassadors in Dermatology and Venereology: An interview with Professor Fabio Ayala